(267 days)
The Biolign® Tlif Interbody Fusion Devices are indicated for use with autograft bone graft in skeletally mature patients with degenerative disc disease (DDD) at one level or two contiguous levels of the lumbar spine (L2 - S1). DDD is defined as backpain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The DDD patients may also have up to Grade I spondylolisthesis at the involved level(s). These patients should be skeletally mature and have six (6) months of non-operative therapy. The Biolign® TLIF Intervertebral fusion devices are used to facilitate fusion in the lumbar spine and are implanted via a postero-lateral approach. The Biolign® intervertebral fusion devices are intended to be used with supplemental fixation systems that have been cleared for use in the lumbosacral spine for example posterior pedicle screw and rod systems.
The Biolign® ACIF System is indicated for use as an intervertebral body fusion device in skeletally mature patients with degenerative disc disease at one level from C3-C7. Cervical disc disease is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. Patients should have six (6) weeks of non-operative treatment. The Biolign® ACIF System is to be used with autograft bone graft and is implanted via an open anterior approach. The Biolign® ACIF System is intended to be used with supplemental fixation systems that have been cleared for in the cervical spine, such as Anterior Cervical plating systems.
The Biolign® STACC ACIF System is indicated for use as an intervertebral body fusion device in skeletally mature patients with degenerative disc disease at one level from C3-C7. Cervical disc disease is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. Patients should have six (6) weeks of non-operative treatment. The Biolign® STACC ACIF System is to be used with autograft bone graft and is implanted via an open anterior approach. The Biolign STACC ACIF system is intended to be used as a stand-alone system using the bone screws provided for fixation. It may also be used with supplemental fixation system that have been cleared for use in the cervical spine, such as cervical plating systems.
The Biolign TLIF device is a slightly curved cage manufactured from Invibio PEEK Optima LT1 with cavities which can be packed with autograft. The cage has tantalum markers which allow accurate and correct placement of the device. The cage is postero-laterally inserted. The cage incorporates a threaded introducer hole on each end and has serrated inferior and superior endplates. It is available in two footprints (30x13mm, and 36x13mm), two lordotic angles (5° and 10°), and a range of heights ranging from 6 - 12mm with 1mm intervals These sizing options allow selection for individual pathology and anatomical conditions. The device is used with supplemental fixation such as screw and rod systems. The Biolign® TLIF system is provided sterile.. The System is single use only.
The Biolign ACIF device is an anatomically correct cage manufactured from Invibio PEEK Optima LT1 with a central cavity which can be packed with autograft. The cage is available in two footprints (15 and 17mm) with a 10° lordotic angle. Cage heights range from 6mm-10mm with 1mm intervals. These sizing options allow selection for individual pathology and anatomical conditions. Tantalum radiographic markers enable clear x-ray control during placement and follow-up. The cage endplates are serrated. The Device is inserted below the anterior surface of the cervical vertebrae. It is used with supplemental cervical plating systems which have prominence from the spine (plate thickness). The Biolign® ACIF system is provided sterile The System is for single use only.
The Biolign® STACC ACIF Interbody Fusion Device is a stand-alone device and does not rely on additional fixation such as cervical plates. The device is an anatomically shaped ring, with a central cavity which can be packed with autograft. It is manufactured of Invibio Peek Optima LT1. Two Tantalum pins are placed in the device to enable radiographic visualization for placement and follow-up evaluations. The superior, and inferior endplates of the device are serrated. Two fixation screws per cage are used as supplemental fixation. These screws are placed into the cage and purchase into the vertebral endplates. The fixation screws are manufactured of Titanium 6Al4V ELI. The footprint of the cage is available in one size (17 x 14mm), and in heights ranging from 5.5 - 9.5mm with 1mm intervals. The cage is available in a domed (superior endplate is domed, and inferior endplate has 3° lordosis angle) and a tapered version (8° lordosis - 4° per endplate) The device is implanted using an anterior approach and after implantation does not stand prominent from the cervical spine. It lies below the anterior surface of the cervical spine. The Biolign® STACC ACIF system is supplied sterile. The System is for single use only.
Here's an analysis of the provided text regarding the acceptance criteria and supporting study for the Biolign® Intervertebral Body Fusion Systems:
It's important to note that this document is a 510(k) Summary, which demonstrates substantial equivalence to a predicate device, rather than a full pre-market approval (PMA) application that would typically require extensive clinical trials. Therefore, the information regarding "acceptance criteria" and "study" is framed within the context of demonstrating substantial equivalence through non-clinical (bench) testing, rather than clinical efficacy.
Acceptance Criteria and Reported Device Performance
The acceptance criteria for these devices are implicitly defined by their substantial equivalence to predicate devices, specifically in terms of design, function, performance, material, sterilization, and intended use. The key performance criteria are primarily mechanical properties, demonstrated through bench testing.
| Acceptance Criteria Category | Specific Criteria (Implicit for Substantial Equivalence) | Reported Device Performance |
|---|---|---|
| Mechanical Performance (TLIF) | Static/Dynamic axial compression strength, Static shear compression strength, Torsion testing, Subsidence resistance comparable to predicate. | "Results drawn from the testing performed, as well as from an engineering rationale, demonstrate that the Biolign TLIF spacer is substantially equivalent in performance to the predicate device." |
| Mechanical Performance (ACIF) | Static axial compression strength, Static shear compression strength, Static torsion testing comparable to predicate. | "Results drawn from the testing performed, as well as from an engineering rationale, demonstrate that the Biolign ACIF spacer is substantially equivalent in performance to the predicate device." |
| Mechanical Performance (STACC ACIF) | Static/Dynamic axial compression strength, Static shear compression strength, Static/Dynamic torsion testing, Screw push-out testing, Tension offset testing, Impact testing comparable to predicate. | "Results drawn from the testing performed, as well as from an engineering rationale, demonstrate that the Biolign STACC spacer is substantially equivalent in performance to the predicate device." |
| Material Biocompatibility | Use of Invibio PEEK Optima LT1 and Tantalum markers, and Titanium 6Al4V ELI (for STACC screws) known to be biocompatible and used in predicate devices. | Stated material composition is identical or similar to predicate devices, implying equivalent biocompatibility. |
| Sterilization | Provision as a sterile product with an established sterilization method. | "The System is provided sterile." |
| Intended Use | Matching indications for use and surgical approaches of predicate devices. | Indications for Use sections confirm alignment with predicate device applications. |
| Design/Function | Anatomical shape, central cavity for autograft, radiographic markers, serrated endplates, sizing options, threaded introducer hole (TLIF), fixation screws (STACC). Design features aim to replicate or be comparable to predicate devices. | Device Descriptions detail features that are presented as substantially equivalent to predicates. |
Study Details
Given this is a 510(k) submission, the "study" primarily refers to non-clinical (bench) testing to demonstrate substantial equivalence, rather than clinical trials.
-
Sample Size Used for the Test Set and Data Provenance:
- Sample Size: The document does not specify the exact sample sizes (e.g., number of cages tested) for the bench tests. It refers to "testing performed" as per ASTM standards.
- Data Provenance: The testing was conducted by Elite Surgical Supplies, which is based in South Africa. The document doesn't specify if the testing was done in South Africa, but it's implied the company managed the tests. The data is retrospective in the sense that it supports an existing product design against established standards.
-
Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications:
- Not Applicable. For non-clinical bench testing, "ground truth" is established by adherence to recognized international standards (e.g., ASTM F2077, ASTM F2267) and engineering principles, rather than expert human consensus on image interpretation or pathology results. The "truth" is the measured mechanical property compared against acceptable limits derived from predicate device performance or standard requirements.
-
Adjudication Method for the Test Set:
- Not Applicable. Adjudication methods like 2+1 or 3+1 are typically used for clinical data review, especially in cases of conflicting expert opinions on diagnoses or outcomes. For bench testing, the results are quantitative measurements interpreted against pre-defined engineering criteria.
-
If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done:
- No. MRMC studies are clinical studies involving multiple human readers evaluating medical images, often to compare diagnostic accuracy with and without AI assistance. This document explicitly states: "Clinical data and conclusions were not needed for this device."
-
If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- No. This device is a physical intervertebral cage, not an algorithm or AI software. Therefore, the concept of "standalone performance" in the context of AI does not apply.
-
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- For the non-clinical (bench) testing, the "ground truth" refers to engineering specifications and established biomechanical standards (e.g., ASTM standards). The performance of the predicate device also serves as a comparative "ground truth" for substantial equivalence.
-
The sample size for the training set:
- Not Applicable. This is a physical medical device, not an AI/ML algorithm. There is no concept of a "training set" in this context.
-
How the ground truth for the training set was established:
- Not Applicable. As there is no training set, there is no ground truth to establish for it.
In summary, the provided document focuses on demonstrating the substantial equivalence of the Biolign® Intervertebral Body Fusion Systems to existing predicate devices through comprehensive non-clinical bench testing. The "acceptance criteria" are intrinsically tied to meeting the mechanical performance characteristics and design specifications comparable to these legally marketed predicate devices, as guided by FDA recommendations and ASTM standards. No clinical studies, expert consensus reviews for ground truth, or AI-specific performance metrics are relevant or discussed in this 510(k) summary.
{0}------------------------------------------------
510(k) SUMMARY: K130274
[As required by 21CFR807.92]
OCT 2:9 2013
Image /page/0/Picture/4 description: The image shows a series of horizontal lines of varying lengths and thicknesses. The lines are arranged in a somewhat stacked formation, with some lines appearing to overlap or be positioned closely together. The lines are black and are set against a white background.
ELITE SURGICAL SUPPLIES (PTY) LTD
Contact detail
| 510(k) Summary - Biolign Intervertebral Cages | ||
|---|---|---|
| Prepared | September 11, 2013 | |
| Name of firm | Elite Surgical Supplies (Pty) Ltd.184 Bessemer Road,Pretoria-West Industrial0183South Africa | |
| Postal Address | P.O. Box 26115ArcadiaPretoria0007South Africa | |
| 510(k) Contact | Rudi VerbeekTechnical Director and Regulatory AffairsTel: +27 12 386 0012Facsimile: +27 12 386 2745Email: rudi@elitesurgical.com | |
| USA Agent | Charise de BarrosElite Surgical USA503 Commerce Park Drive, Suite HMariettaGeorgia 30060USAFacsimile: 770-590-5152Email: charise@alloutautousa.com |
Elite Surgical Supplies Biolign® Intervertebral Body Fusion Systems Page 1
{1}------------------------------------------------
Product detail
| Biolign® Transforaminal Lumbar Intervertebral Fusion (TLIF) device. | |
|---|---|
| Classification | 21 CFR 888.3080 Intervertebral body fusion deviceClass II (Special Controls)Orthopaedic and Rehabilitation Devices Panel (87)Product Code MAX (Intervertebral body fusion device with bone graft,Lumbar). |
| Predicates | Spinecraft ORIO-TL - K090887 |
| DeviceDescription | The Biolign TLIF device is a slightly curved cage manufacturedfrom Invibio PEEK Optima LT1 with cavities which can be packedwith autograft. The cage has tantalum markers which allowaccurate and correct placement of the device. The cage is postero-laterally inserted. The cage incorporates a threaded introducer holeon each end and has serrated inferior and superior endplates. It isavailable in two footprints (30x13mm, and 36x13mm), two lordoticangles (5° and 10°), and a range of heights ranging from 6 - 12mmwith 1mm intervals These sizing options allow selection forindividual pathology and anatomical conditions. The device is usedwith supplemental fixation such as screw and rod systems. TheBiolign® TLIF system is provided sterile.. The System is single useonly. |
| Indicationsforuse | The Biolign® Tlif Interbody Fusion Devices are indicated for use withautograft bone graft in skeletally mature patients with degenerativedisc disease (DDD) at one level or two contiguous levels of thelumbar spine (L2 - S1).DDD is defined as backpain of discogenic origin with degenerationof the disc confirmed by history and radiographic studies. The DDDpatients may also have up to Grade I spondylolisthesis at theinvolved level(s). These patients should be skeletally mature andhave six (6) months of non-operative therapy.The Biolign® TLIF Intervertebral fusion devices are used to facilitatefusion in the lumbar spine and are implanted via a postero-lateralapproach.The Biolign® intervertebral fusion devices are intended to be usedwith supplemental fixation systems that have been cleared for use inthe lumbosacral spine for example posterior pedicle screw and rodsystems. |
| Comparison ofthe device tothe predicate | Elite Surgical Supplies' Biolign® TLIF Spacer is substantiallyequivalent to the predicates in design, function, performance,material, sterilization and intended use. |
.
.
:
.
:
.
:
Elite Surgical Supplies
Biolign® Intervertebral Body Fusion Systems
Page 2
. .
.
{2}------------------------------------------------
| device(s) | |
|---|---|
| Performancedata (Non-Clinical) | Elite Surgical Supplies conducted the following bench testing asrecommended by FDA guidances and in accordance with ASTM2077 and ASTM 2267: Static and Dynamic axial compression, Staticshear compression, torsion testing and subsidence testing.Results drawn from the testing performed, as well as from anengineering rationale, demonstrate that the Biolign TLIF spacer issubstantially equivalent in performance to the predicate device. |
| Performancedata (Clinical) | Clinical data and conclusions were not needed for this device. |
| Biolign® Anterior Cervical Interbody Fusion (ACIF) System | |
|---|---|
| Classification | 21 CFR 888.3080 Intervertebral body fusion deviceClass II (Special Controls)Orthopaedic and Rehabilitation Devices Panel (87)Product Code ODP (Intervertebral body fusion device with bone graft,Cervical). |
| Predicates | AMT Shell Cervical cage- K080401 |
| DeviceDescription | The Biolign ACIF device is an anatomically correct cagemanufactured from Invibio PEEK Optima LT1 with a central cavitywhich can be packed with autograft. The cage is available in twofootprints (15 and 17mm) with a 10° lordotic angle. Cage heightsrange from 6mm-10mm with 1mm intervals. These sizing optionsallow selection for individual pathology and anatomical conditions.Tantalum radiographic markers enable clear x-ray control duringplacement and follow-up. The cage endplates are serrated. TheDevice is inserted below the anterior surface of the cervicalvertebrae. It is used with supplemental cervical plating systems whichhave prominence from the spine (plate thickness). The Biolign® ACIFsystem is provided sterile The System is for single use only. |
| Indications foruse | The Biolign® ACIF System is indicated for use as an intervertebralbody fusion device in skeletally mature patients with degenerativedisc disease at one level from C3-C7. Cervical disc disease is definedas discogenic pain with degeneration of the disc confirmed by historyand radiographic studies. Patients should have six (6) weeks of non-operative treatment. The Biolign® ACIF System is to be used withautograft bone graft and is implanted via an open anterior approach.The Biolign® ACIF System is intended to be used with supplementalfixation systems that have been cleared for in the cervical spine, suchas Anterior Cervical plating systems. |
| Comparison ofthe device tothe predicate | Elite Surgical Supplies' Biolign® ACIF Spacer is substantiallyequivalent to the predicates in design, function, performance,material, sterilization and intended use. |
Elite Surgical Supplies
Biolign® Intervertebral Body Fusion Systems
Page 3
: .
{3}------------------------------------------------
| device(s) | |
|---|---|
| Performancedata (Non-Clinical) | Elite Surgical Supplies conducted the following bench testing asrecommended by FDA guidances and in accordance with ASTM2077: Static axial compression, Static shear compression, and statictorsion testing.Results drawn from the testing performed, as well as from anengineering rationale, demonstrate that the Biolign ACIF spacer issubstantially equivalent in performance to the predicate device. |
| Performancedata (Clinical) | Clinical data and conclusions were not needed for this device. |
| Biolign® Stand Alone Cervical Cage (STACC) ACIF System | |
|---|---|
| Classification | 21 CFR 888.3080 Intervertebral body fusion deviceClass II (Special Controls)Orthopaedic and Rehabilitation Devices Panel (87)Product Code OVE (Intervertebral fusion device with integratedfixation, cervical). |
| Predicates | Surgicraft Ltd Stalif - K072415 |
| DeviceDescription | The Biolign® STACC ACIF Interbody Fusion Device is a stand-alone device and does not rely on additional fixation such ascervical plates. The device is an anatomically shaped ring, with acentral cavity which can be packed with autograft. It ismanufactured of Invibio Peek Optima LT1. Two Tantalum pins areplaced in the device to enable radiographic visualization forplacement and follow-up evaluations. The superior, and inferiorendplates of the device are serrated. Two fixation screws per cageare used as supplemental fixation. These screws are placed intothe cage and purchase into the vertebral endplates. The fixationscrews are manufactured of Titanium 6Al4V ELI. The footprint ofthe cage is available in one size (17 x 14mm), and in heightsranging from 5.5 - 9.5mm with 1mm intervals. The cage is availablein a domed (superior endplate is domed, and inferior endplate has3° lordosis angle) and a tapered version (8° lordosis - 4° perendplate) The device is implanted using an anterior approach andafter implantation does not stand prominent from the cervical spine.It lies below the anterior surface of the cervical spine. The Biolign®STACC ACIF system is supplied sterile. The System is for singleuse only. |
| Indicationsfor use | The Biolign® STACC ACIF System is indicated for use as anintervertebral body fusion device in skeletally mature patients withdegenerative disc disease at one level from C3-C7. Cervical discdisease is defined as discogenic pain with degeneration of the discconfirmed by history and radiographic studies. Patients should have |
Elite Surgical Supplies
Biolign® Intervertebral Body Fusion Systems
{4}------------------------------------------------
| six (6) weeks of non-operative treatment. The Biolign® STACC ACIFSystem is to be used with autograft bone graft and is implanted viaan open anterior approach. The Biolign STACC ACIF system isintended to be used as a stand-alone system using the bone screwsprovided for fixation. It may also be used with supplemental fixationsystem that have been cleared for use in the cervical spine, such ascervical plating systems. | |
|---|---|
| Comparison ofthe device tothe predicatedevice(s) | Elite Surgical Supplies' Biolign® STACC Spacer is substantiallyequivalent to the predicates in design, function, performance,material, sterilization and intended use. |
| Performancedata (Non-Clinical) | Elite Surgical Supplies conducted the following bench testing asrecommended by FDA guidances and in accordance with ASTM2077: Static and dynamic axial compression, Static shearcompression, and static and dynamic torsion testing, screw push-outtesting, tension offset testing, and impact testing.Results drawn from the testing performed, as well as from anengineering rationale, demonstrate that the Biolign STACC spacer issubstantially equivalent in performance to the predicate device. |
| Performancedata (Clinical) | Clinical data and conclusions were not needed for this device. |
Elite Surgical Supplies
Biolign® Intervertebral Body Fusion Systems
{5}------------------------------------------------
Image /page/5/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the circle is an abstract symbol that resembles an eagle or bird-like figure.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 29, 2013
Elite Surgical Supplies (Pty) Limited Mr. Rudi Verbeek Technical Director P.O. Box 26115 Arcadia Pretoria 0007 South Africa
Re: K130274
Trade/Device Name: Biolign® ACIF System Biolign® STACC ACIF System Biolign® TLIF Intervertebral Body Fusion Device Regulation Number: 21 CFR 888.3080 Regulation Name: Intervertebral body fusion device Regulatory Class: Class II Product Code: OVE, MAX, ODP Dated: September 11, 2013 Received: September 25, 2013
Dear Mr. Verbeek:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act Control Concession Company Construction of Children ・・・・・・・・・・・・
{6}------------------------------------------------
Page 2 - Mr. Rudi Verbeek
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.goy/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Erin=FDKéith
for
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{7}------------------------------------------------
Indications for Use ·
510(k) Number (if known) K130274
Device Name Biolign® ACIF System
Indications for Use (Describe)
The Biolign® ACIF System is indicated for use as an intervertebral body fusion device in skeletally mature paients with degenerative disc disease at one level from C3-C7. Cervical discogenic pain with degeneration of the disc confirmed by history and radiographic studies. Patients should have six (6) weeks of non-operative treatment. The Biolign® ACIF System is to be used with autograft bone graft and is implanted via an open anterior approach. The Biolign® ACIF System is intended to be used with supplemental fixation systems such as Anterior Cervical plating systems.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
Anton E. Dmitri Division of Orthopied
{8}------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K130274
Device Name
Biolign® TLIF Intervertebral Body Fusion Device
Indications for Use (Describe)
The Biolign® TLIF Intervertebral Body Fusion Devices are indicated for use with autograft bone graft in skeletally mature patients with degenerative disc disease (DDD) at one level or two contiguous levels of the lumbar spine (L2 - S1).
DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radios. The DDd patients may also have up to Grade I spondylolisthesis at the involved level(s). These patients should be skeletally mature and have six {6) months of non-operative therapy.
The Biolign® TLIF Intervertebral Body Fusion Devices are used to facilitate fusion in the lumbar spine and are implanted via a postero-lateral approach.
The Biolign® Intervertebral Body Fusion Devices are intended to be used with supplemental fixation systems that have been cleared for use in the lumbosacral spine, for example posterior pedicle screw and rod systems.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
[ ] Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
Division o
{9}------------------------------------------------
Indications for Use
510(k) Number (if known) K130274
Device Name Biolign® STACC ACIF System
Diognes STRCC RICH System
Indications for Use (Describe)
The Biolign® STACC ACIF System is indicated for use as an intervertebral body fusion device in skeletally mature patients with degenerative disc disease at one level from C3-C7. Cervical disc disease is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. Patients should have six (6) weeks of non-operative treatment. The Biolign® STACC ACIF System is to be used with autograft bone graft and is implanted via an open anterior approach. The Biolign® STACC ACIF system is intended to be used as a stand-alone screws provided for fixation. It may also be used with supplemental fixation systems that have been cleared for use in the cervical spine, such as cervical plating systems.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
[] Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
Anton E. Dmitri Division of Orthopedic
FORM FDA 3881 (9/13)
Form Approved: OMB No. 0910-0120 Expiration Date: December 31, 2013 See PRA Statement on last page.
§ 888.3080 Intervertebral body fusion device.
(a)
Identification. An intervertebral body fusion device is an implanted single or multiple component spinal device made from a variety of materials, including titanium and polymers. The device is inserted into the intervertebral body space of the cervical or lumbosacral spine, and is intended for intervertebral body fusion.(b)
Classification. (1) Class II (special controls) for intervertebral body fusion devices that contain bone grafting material. The special control is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intervertebral Body Fusion Device.” See § 888.1(e) for the availability of this guidance document.(2) Class III (premarket approval) for intervertebral body fusion devices that include any therapeutic biologic (e.g., bone morphogenic protein). Intervertebral body fusion devices that contain any therapeutic biologic require premarket approval.
(c)
Date premarket approval application (PMA) or notice of product development protocol (PDP) is required. Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.